Q4 2017 Holdings
Filed 2018-02-08 | 10 holdings | $113.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-05-03) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kala Pharmaceuticals, Inc.A | Common Stock | 483119103 | $34.3K | 1,857,582 | 30.3% |
| Arsanis, Inc. | Common Stock | 042873109 | $23.8K | 1,868,957 | 21.0% |
| Selecta Biosciences, Inc.(SELBUSD)A | Common Stock | 816212104 | $15.8K | 1,606,813 | 13.9% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $15.1K | 2,473,186 | 13.3% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $7.7K | 1,875,524 | 6.8% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $6.4K | 1,827,992 | 5.6% |
| Pulmatrix Inc.A | Common Stock | 74584P103 | $3.9K | 2,796,407 | 3.5% |
| Trevena, Inc. | Common Stock | 89532E109 | $3.3K | 2,053,540 | 2.9% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $2.3K | 1,968,606 | 2.0% |
| Dare Bioscience, Inc.(CERUEUR)A | Common Stock | 23666P101 | $706 | 326,243 | 0.6% |